http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2192228-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82dd35e5aa635176b3f1673638af6dd1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
filingDate 1996-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1561c66f70929fff54678de30c840c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81a2d01fe154d5537c4eec78fab5f1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7faf97af762fc4ba8cb62fd4ca1f3e43
publicationDate 1997-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2192228-A1
titleOfInvention Pharmaceutical compositions based on mequitazine
abstract The subject of this invention is a ready-for-use collyrium intended for the treatment of ocular allergies, comprising, in aqueous solution, mequitazine and a .beta.- or a .gamma.-cyclodextrin optionally etherified by C1-C4 alkyl or C1-C4 hydroxyalkyl groups, the said cyclodextrin being present in at least a molar ratio in relation to mequitazine.
priorityDate 1995-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID254363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID254363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415781681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535245

Total number of triples: 39.